ID

33870

Description

Study ID:103860/269 Clinical Study ID:103860/269 (HBV-269) Study Title: Phase II study to evaluate the immunogenicity of GSK Biologicals' preservative-free Engerix-B and thiomersal-free Engerix-B vaccines compared to Engerix™-B and evaluate safety and reactogenicity of each vaccine when administered intramuscularly according to a 0, 1, 6 month schedule in healthy volunteers Patient Level Data:Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: Hepatitis B Vaccine, Recombinant Trade Name: Engerix-B Study Indication: Hepatitis B

Mots-clés

Versions (1)
  1. 04/01/2019 04/01/2019 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

4 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Immunogenicity, safety and reactogenicity of preservative-free Engerix-B and thiomersal-free Engerix-B vaccines compared to Engerix™️-B

Anglais

Informed Consent

1 Formulaires  
  1. StudyEvent: ODM
    1. Informed Consent
Informed Consent
Description

Informed Consent

Alias
UMLS CUI-1
C0021430
UMLS CUI-2
C0030705
Subject’s first name and family name
Description

The aims and procedures of this study have been clearly explained to me and I have read the preceding information sheet and understood the information provided. I agree to be enrolled in the study. I understand that I have the right to decline to enter the study and to withdraw from it at any time for any reasons, without consequence to my present or future health care and attention which I receive from my healthcare provider. I have been made aware of my right to access and request correction of my personal data. I acknowledge that I have received a copy of this form for future reference. I hereby freely give my consent to take part in this study.

Type de données

text

Alias
UMLS CUI [1]
C1299487
Participant’s signature
Description

Participant, Signature

Type de données

text

Alias
UMLS CUI [1,1]
C0679646
UMLS CUI [1,2]
C1519316
Participant’s main address
Description

Patient address

Type de données

text

Alias
UMLS CUI [1]
C0421449
Participant’s phone number
Description

Participant, Telephone Number

Type de données

integer

Alias
UMLS CUI [1,1]
C0679646
UMLS CUI [1,2]
C1515258
Date
Description

Informed Consent, Date in time

Type de données

date

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0011008
Time
Description

Informed Consent, Time

Type de données

time

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0040223
Witness
Description

Informed Consent, Witnesses

Type de données

text

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0682356
Statement by Doctor, Nurse or Project Assistant who conducted the informed consent discussion
Description

Statement by Doctor, Nurse or Project Assistant who conducted the informed consent discussion

Alias
UMLS CUI-1
C0021430
UMLS CUI-2
C0035173
Name
Description

I have carefully explained the nature, demands and foreseeable risks and benefits of the vaccination study to the person named above and witnessed the completion of the written consent form.

Type de données

text

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0035173
UMLS CUI [1,3]
C0027365
Signature
Description

Informed Consent, Research Personnel, Signature

Type de données

text

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0035173
UMLS CUI [1,3]
C1519316
Designation
Description

Informed Consent, Research Personnel, Occupations

Type de données

text

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0035173
UMLS CUI [1,3]
C0028811
Date
Description

Informed Consent, Research Personnel, Date in time

Type de données

date

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0035173
UMLS CUI [1,3]
C0011008
Time
Description

Informed Consent, Research Personnel, Time

Type de données

time

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0035173
UMLS CUI [1,3]
C0040223
Retour au début de la page

Similar models

Informed Consent

1 Formulaires
  1. StudyEvent: ODM
    1. Informed Consent
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Informed Consent
C0021430 (UMLS CUI-1)
C0030705 (UMLS CUI-2)
Patient Name
Item
Subject’s first name and family name
text
C1299487 (UMLS CUI [1])
Participant, Signature
Item
Participant’s signature
text
C0679646 (UMLS CUI [1,1])
C1519316 (UMLS CUI [1,2])
Patient address
Item
Participant’s main address
text
C0421449 (UMLS CUI [1])
Participant, Telephone Number
Item
Participant’s phone number
integer
C0679646 (UMLS CUI [1,1])
C1515258 (UMLS CUI [1,2])
Informed Consent, Date in time
Item
Date
date
C0021430 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Informed Consent, Time
Item
Time
time
C0021430 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
Informed Consent, Witnesses
Item
Witness
text
C0021430 (UMLS CUI [1,1])
C0682356 (UMLS CUI [1,2])
Item Group
Statement by Doctor, Nurse or Project Assistant who conducted the informed consent discussion
C0021430 (UMLS CUI-1)
C0035173 (UMLS CUI-2)
Informed Consent, Research Personnel, Name
Item
Name
text
C0021430 (UMLS CUI [1,1])
C0035173 (UMLS CUI [1,2])
C0027365 (UMLS CUI [1,3])
Informed Consent, Research Personnel, Signature
Item
Signature
text
C0021430 (UMLS CUI [1,1])
C0035173 (UMLS CUI [1,2])
C1519316 (UMLS CUI [1,3])
Informed Consent, Research Personnel, Occupations
Item
Designation
text
C0021430 (UMLS CUI [1,1])
C0035173 (UMLS CUI [1,2])
C0028811 (UMLS CUI [1,3])
Informed Consent, Research Personnel, Date in time
Item
Date
date
C0021430 (UMLS CUI [1,1])
C0035173 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Informed Consent, Research Personnel, Time
Item
Time
time
C0021430 (UMLS CUI [1,1])
C0035173 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial